Ltr Pharma Fpo has released a press release.
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from LTR Pharma
- Commercial Update and Regulatory Progress
- LTR Pharma to Showcase SPONTAN Data at Urology Conference
- LTR Signs Symbion National Pharmacy Distribution Agreement
- Response to ASX Query Letters
- Agreement with Men's Health Pharmacy for SPONTAN access
Later from LTR Pharma
- LTR Signs Collaborative Agreement to Develop OMD Nasal Spray
- SPONTAN Expands Patient Access via National Pharmacy Network
- Urological Expert Appointed to LTR Scientific Advisory Board
- LTP Completes Extractables Study Milestone for SPONTAN
- SPONTAN 5x Faster Onset Validated in EU Journal
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma